Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

3.07
Delayed Data
As of Aug 18
 +0.04 / +1.32%
Today’s Change
0.50
Today|||52-Week Range
3.30
+468.52%
Year-to-Date

Today’s Trading

Previous close3.03
Today’s open3.04
Day’s range2.95 - 3.08
Volume2,633,582
Average volume (3 months)4,374,297
Market cap$363.2M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-44.44%
Earnings growth (this year)-11.54%
Earnings growth (next 5 years)--
Revenue growth (last year)-86.78%
P/E ratioNM
Price/Sales14.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AVDLAvadel Pharmaceutica...+0.12+1.39%
GLYCGlycoMimetics Inc+0.04+0.38%
RARXRa Pharmaceuticals I...-0.16-1.05%
SVASinovac Biotech Ltd+0.02+0.30%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$2.5M
Annual profit (last year)-$26.9M
Net profit margin-1,069.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Matthew D. Dallas
Corporate headquarters
Cambridge, Massachusetts

Forecasts